Arden Trust’s Rentokil RTO Stock Holding History

Arden Trust’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,894	Closed	-$230K	–	265
2023 Q2	$230K	Sell	5,894 -10,934	-65%	-$428K	0.04%	226
2023 Q1	$614K	Sell	16,828 -3,906	-19%	-$123K	0.11%	156
2022 Q4	$639K	Buy	+20,734	New	+$644K	0.13%	141

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MNG

Manning & Napier Group Fairport, New York $8.76B AUM 23.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arden Trust's RTO Position: Q3 2023 in Review

Arden Trust sold out of Rentokil (RTO) in Q3 2023, closing a stake of 5,894 shares — an estimated $230K sold.

Arden Trust first reported a position in RTO in Q4 2022 and held it in 3 quarters. The position peaked at $639K in Q4 2022. 193 funds tracked by Wall St. Rank hold RTO as of Q3 2023.

Arden Trust reported no remaining Rentokil position as of Q3 2023 after selling out during the quarter.
Arden Trust sold 5,894 Rentokil shares in Q3 2023, an estimated $230K.
Arden Trust first reported a position in Rentokil in Q4 2022 and held it in 3 quarters.
Arden Trust's Rentokil position peaked at $639K in Q4 2022.
193 funds tracked by Wall St. Rank held Rentokil as of Q3 2023.

Based on Arden Trust's 13F filing for Q3 2023, filed 10 Oct 2023.